ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 772

Molecular Mechanism for the Therapeutic Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers of Systemic Sclerosis

Yukiko Kamogawa1, Hiroshi Fujii1, Tsuyoshi Shirai1, Tomonori Ishii2 and Hideo Harigae1, 1Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan, 2Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Angiogenesis, endothelial cells and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Digital ulcers (DUs) are the most common skin manifestations in systemic sclerosis (SSc). DUs in SSc are not usually caused by vasculitis and are often refractory to conventional immunosuppressive therapies. Extracorporeal shock wave therapy (ESWT) has been used to treat urinary stones since 1980s. The therapy has also been applied to treat various diseases such as chronic tendinopathy, ischemic heart disease, and wound healing disorders. Previously, we reported that the low energy ESWT dramatically improved refractory DUs in SSc (Saito et.al. Tohoku J. Exp. Med. 238:19, 2016). Because ESWT was applied on palms and forearms distant from DUs, we considered that the healing effect of ESWT on DUs may be due to enhanced angiogenesis via some angiogenic factors rather than a direct physical stimulus on ulcers. However, the precise molecular mechanism remains unknown. In this study, we tried to clarify the molecular basis of shock wave (SW) treatment on dermal endothelial cells using in vitro SW treatment system. We found that FBJ murine osteosarcoma viral oncogene homolog B (FOSB), which is a component of multipotent transcriptional factor AP-1, was prominently increased after SW treatment. We also examined the functional consequence of FOSB on angiogenesis.

Methods: (1) Human Dermal Microvascular Endothelial Cells (HDMECs) were cultured on a cover glass with 2.5% agarose gel (Fig-1) and treated with SW. RNA was extracted from HDMECs 2 h after SW treatment, and gene expression profiling was analyzed using microarray (Agilent). (2) FOSB expression after SW treatment was measured using RT-PCR. (3) FOSB-expressing HDMECs were stimulated with serum, and vascular growth factor A (VEGFA) induction was evaluated using RT-PCR.

Results: In the culture system shown in Fig-1, HDMECs were stable without any significant detachment or death of cells after SW treatment. The microarray analysis revealed that FOSB gene expression level was significantly elevated (>10-fold, p < 0.05) after SW treatment in three independent experiments. In RT-PCR analysis, FOSB gene expression level was also increased in proportion to SW energy at 1 h after the treatment. Aberrant expression of FOSB in HDMECs increased VEGFA induction by stimulation with serum (Fig-2)

Conclusion: SW treatment elevated FOSB gene expression in HDMECs, which directly led to increased sensitivity for VEGFA induction, suggesting that FOSB may be a master regulator responsible for the angiogenic effect of ESWT. This finding may help in the development of more effective strategies using ESWT for DUs in SSc.


Disclosure: Y. Kamogawa, None; H. Fujii, None; T. Shirai, None; T. Ishii, Chugai, Ono, Pfizer, Mitsubishi-Tanabe, Astellas, 8; H. Harigae, None.

To cite this abstract in AMA style:

Kamogawa Y, Fujii H, Shirai T, Ishii T, Harigae H. Molecular Mechanism for the Therapeutic Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers of Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/molecular-mechanism-for-the-therapeutic-effect-of-extracorporeal-shock-wave-therapy-on-digital-ulcers-of-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-mechanism-for-the-therapeutic-effect-of-extracorporeal-shock-wave-therapy-on-digital-ulcers-of-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology